(Q45740307)

English

Determination of the protective effects of neutralizing anti-hepatitis B virus (HBV) immunoglobulins by epitope mapping with recombinant HBV surface-antigen proteins

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Determination of the protective effects of neutralizing anti-hepatitis B virus (HBV) immunoglobulins by epitope mapping with recombinant HBV surface-antigen proteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Park JH

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cho EW

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Lee YJ

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Shin SY

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Kim KL

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

703-710

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

The molecular biology of the hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Hepatitis B Immune Globulin for Accidental Exposures among Medical Personnel: Final Report of a Multicenter Controlled Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Separation of Two Hepatitis B Human Antibody Fractions by Cold-Ethanol Precipitation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Generation and characterization of a novel fusion partner cell line for the production of human macrophage hybridoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

High level expression of hepatitis B virus preS1 peptide in Escherichia coli

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Failure of hepatitis B immune globulin to protect against exp infection in chimpanzees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2000.TB02552.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2000.TB02552.X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45740307&oldid=2079890559"